n(g),n(g')-dimethyl-l-arginine has been researched along with Cardiomegaly in 3 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study aimed to investigate the protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats (SHRs) through the Cys-C/Wnt signaling pathway." | 7.85 | Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway. ( Chen, HW; Feng, J; Pi, LJ; Wang, J; Zhan, DQ, 2017) |
| "Persistent cardiac hypertrophy eventually leads to deterioration of heart function and changes to normal morphology." | 5.51 | Interleukin enhancement binding factor 3 inhibits cardiac hypertrophy by targeting asymmetric dimethylarginine-nitric oxide. ( Ge, LJ; Peng, XD; Sun, JC; Tan, X; Wang, WZ; Yang, RH, 2019) |
| "We suggest that elevated levels of ADMA in the PF of patients indicate upregulated RAS and reduced bioavailability of NO, which can contribute to the development of cardiac hypertrophy and remodeling." | 5.42 | Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy. ( Biri, B; Cziraki, A; Keki, S; Koller, A; Nemeth, Z; Szabados, S, 2015) |
| "The study aimed to investigate the protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats (SHRs) through the Cys-C/Wnt signaling pathway." | 3.85 | Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway. ( Chen, HW; Feng, J; Pi, LJ; Wang, J; Zhan, DQ, 2017) |
| "Persistent cardiac hypertrophy eventually leads to deterioration of heart function and changes to normal morphology." | 1.51 | Interleukin enhancement binding factor 3 inhibits cardiac hypertrophy by targeting asymmetric dimethylarginine-nitric oxide. ( Ge, LJ; Peng, XD; Sun, JC; Tan, X; Wang, WZ; Yang, RH, 2019) |
| "We suggest that elevated levels of ADMA in the PF of patients indicate upregulated RAS and reduced bioavailability of NO, which can contribute to the development of cardiac hypertrophy and remodeling." | 1.42 | Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy. ( Biri, B; Cziraki, A; Keki, S; Koller, A; Nemeth, Z; Szabados, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, RH | 1 |
| Tan, X | 1 |
| Ge, LJ | 1 |
| Sun, JC | 1 |
| Peng, XD | 1 |
| Wang, WZ | 1 |
| Nemeth, Z | 1 |
| Cziraki, A | 1 |
| Szabados, S | 1 |
| Biri, B | 1 |
| Keki, S | 1 |
| Koller, A | 1 |
| Feng, J | 1 |
| Chen, HW | 1 |
| Pi, LJ | 1 |
| Wang, J | 1 |
| Zhan, DQ | 1 |
3 other studies available for n(g),n(g')-dimethyl-l-arginine and Cardiomegaly
| Article | Year |
|---|---|
Interleukin enhancement binding factor 3 inhibits cardiac hypertrophy by targeting asymmetric dimethylarginine-nitric oxide.
Topics: Amidohydrolases; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arginine; Cardiom | 2019 |
Elevated Levels of Asymmetric Dimethylarginine (ADMA) in the Pericardial Fluid of Cardiac Patients Correlate with Cardiac Hypertrophy.
Topics: Adult; Arginine; Cardiomegaly; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Myocardiu | 2015 |
Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway.
Topics: Abietanes; Animals; Arginine; Cardiomegaly; Cardiovascular Agents; Collagen Type I; Collagen Type I, | 2017 |